StemCells, Inc. Moves to NASDAQ National Market
Related News: Stem Cell Companies, Stem Cell InvestmentPALO ALTO, Calif., (September 30, 2005) – StemCells, Inc. (NASDAQ: STEM) today announced that the Nasdaq Stock Market has approved its application to transfer the listing of its common stock to the National Market from the Capital Market.
The Company’s stock will continue to trade under its current symbol, STEM.
"Our move to the Nasdaq National Market reflects the continued maturation of StemCells, Inc. as a publicly traded company. We believe our listing on the National Market will better serve investors by providing greater liquidity and visibility for our shares." said Martin McGlynn, President and CEO of StemCells, Inc.
Source StemCells, Inc.
Posted on October 17, 2005 05:55 PM